Although proton pump inhibitors may reduce heartburn and gastrointestinal bleeding in hospital patients, the therapy may also raise their mortality risk, according to a recent study published in the ...

The most widely used H. pylori treatments are 1-week triple therapy regimens involving twice daily dosing with a PPI, clarithromycin 500 mg and either amoxicillin 1 g or metronidazole 400−500 mg.

After pH testing of either type, abnormal acid exposure time (AET) when the pH in the lower esophagus is greater than 6% ...

NEW YORK (Reuters Health) - In patients taking aspirin to lower their risk of having a heart attack or stroke, lifelong therapy with a proton pump inhibitor (PPI), which includes drugs such as Nexium ...

PPIs reduce gastric ulters (shown) but may weaken bones Taking PPIs for several years can significantly raise the risk of osteoporosis-related fracture. Researchers have good news and bad news for ...

A study explored outcomes among patients living with newly diagnosed eosinophilic esophagitis (EoE) who demonstrated lack of histological response following proton pump inhibitor (PPI) treatment.

What are the consequences of taking proton pump inhibitors (PPIs) over an extended period of time? It seems we start patients on these medications and never discontinue them. — CHERIE HOWK, PhD, ...

The use of proton pump inhibitors with anti-cancer therapies was associated with worse survival outcomes in patients with breast cancer. Concomitant use of proton pump inhibitors and other everyday ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Proton pump ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. “These findings suggest that the clinical benefits of ...

Please provide your email address to receive an email when new articles are posted on . More than half of patients in the dupilumab groups achieved histologic remission at week 16. Higher-exposure ...